CD274 - CD274 molecule Gene
Also Known as PDL1
Species: Sus scrofa
About CD274
This gene has 2 transcripts (splice variants), 102 orthologues and 8 paralogues. Broad expression in spleen (RPKM 1.1), ovary (RPKM .8) and 8 other tissues.
CD274 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001025221.1 | NP_001020392.1 | programmed cell death 1 ligand 1 precursor |
CD274 Protein Structure
IgV_PDl1: cd20947 (44 - 64)
IgV_PDl1: cd20947 (44 - 47)
IgV_PDl1: cd20947 (44 - 153)
IgV_PDl1: cd20947 (49 - 54)
IgV_PDl1: cd20947 (56 - 64)
IgV_PDl1: cd20947 (65 - 76)
IgV_PDl1: cd20947 (76 - 82)
IgV_PDl1: cd20947 (77 - 85)
IgV_PDl1: cd20947 (86 - 91)
IgV_PDl1: cd20947 (86 - 97)
IgV_PDl1: cd20947 (93 - 97)
IgV_PDl1: cd20947 (98 - 139)
IgV_PDl1: cd20947 (107 - 111)
IgV_PDl1: cd20947 (119 - 126)
IgV_PDl1: cd20947 (130 - 140)
IgV_PDl1: cd20947 (140 - 144)
IgV_PDl1: cd20947 (144 - 153)
IgV_PDl1: cd20947 (145 - 153)
Ig: cl11960 (168 - 246)
Ig: cd00096 (173 - 177)
Ig: cd00096 (186 - 195)
Ig: cd00096 (217 - 221)
Ig: cd00096 (228 - 233)
Ig: cd00096 (243 - 246)
- 0
- 100
- 200
- 300
- 361 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
programmed cell death 1 ligand 1 |
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-P990014 | Danburstotug | Inhibitor | 98.76% | Phase 2 |
| HY-P990623 | MDX-1105 | Inhibitor | ≥99.0% | Phase 1 |
| HY-P991354 | GR-1405 | Antagonist | / | Phase 1 |
| HY-P991356 | FAZ-053 | Antagonist | / | Phase 1 |
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS02217 | CD274 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS02218 | Cd274 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS02219 | Cd274 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-14243 | CEP-14083 | Inhibitor | / | Unkown |
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99903 | Simridarlimab | Inhibitor | 99.81% | Unkown |
| HY-P990899 | Amostomig | 97.931% | Unkown | |
| HY-P991024 | Solabafusp alfa | Inhibitor | 97.17% | Unkown |
| HY-P991151 | Opamtistomig | Inhibitor | 99.69% | Unkown |
| HY-P99698 | Lesabelimab | Inhibitor | 97.34% | Unkown |
| HY-P991355 | PDL-GEX | Antagonist | / | Unkown |
| HY-P991357 | STT-001 | Antagonist | / | Unkown |
| HY-P992385 | IMM25011 | Inhibitor | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service